Pfizer Inc (NYSE:PFE) shares, rose in value, with the stock price up by 0.39% to the previous day’s close as strong demand from buyers drove the stock to $25.47.
Actively observing the price movement in the recent trading, the stock is buoying the session at $25.37, falling within a range of $25.26 and $25.495. The value of beta (5-year monthly) is 0.615 whereas the PE ratio is 34.24 over 12-month period. Referring to stock’s 52-week performance, its high was $31.54, and the low was $24.48. On the whole, PFE has fluctuated by -4.68% over the past month.
With the market capitalization of Pfizer Inc currently standing at about $144.34 billion, investors are eagerly awaiting this quarter’s results, scheduled for in January. The company’s Forward Dividend Ratio is 1.68, with its dividend yield at 6.60%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PFE’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 6.71, with the price of PFE currently trading nearly -0.16% and -6.43% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.55, while the 7-day volatility ratio is showing 2.15% which for the 30-day chart, stands at 2.30%. Furthermore, Pfizer Inc (PFE)’s beta value is 0.62, and its average true range (ATR) is 0.53.
A comparison of Pfizer Inc (PFE) with its peers suggests the former has fared considerably weaker in the market. PFE showed an intraday change of 0.39% in today’s session so far, and over the past year, it shrunk by -4.46%%.
Data on historical trading for Pfizer Inc (NYSE:PFE) indicates that the trading volumes over the past 10 days have averaged 39.19 and over the past 3 months, they’ve averaged 39.41 million. According to company’s latest data on outstanding shares, there are 5.67 billion shares outstanding.
Nearly 0.03% of Pfizer Inc’s shares belong to company insiders and institutional investors own 67.54% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 90.38 million shares as on 2024-11-29, resulting in a short ratio of 1.71. According to the data, the short interest in Pfizer Inc (PFE) stood at 160.00 of shares outstanding as of 2024-11-29; the number of short shares registered in 2024-10-31 reached 61.87 million. The stock has fallen by -11.53% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PFE stock heading into the next quarter.
